AUM$57.0M
Expense Ratio0.59%
NAV$32.37
Holdings29
InceptionMay 21, 2024
Price Chart
Key Statistics
Previous Close
$31.59Day Range
$31.36$31.84
52-Week Range
$20.67$37.01
Avg Volume
27.6KDividend Yield
1.27%Expense Ratio
0.59%AUM
$57.0MShares Outstanding
1.3MSector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 99.70% |
| Cash & Others | 1.33% |
| Financial Services | -0.13% |
| Technology | -0.90% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 45.71% |
| Denmark | 18.65% |
| China | 14.88% |
| Japan | 5.10% |
| Switzerland | 4.24% |
| South Korea | 3.68% |
| United Kingdom | 3.59% |
| Hong Kong | 3.03% |
| Singapore | 0.81% |
| Other | 0.30% |
Fund Information
- Issuer
- Roundhill Investments
- Category
- Healthcare
- Types
- Pharma
- Inception Date
- May 21, 2024
- Exchange
- NASDAQ
- Description
- Roundhill believes that weight loss drugs, including GLP-1 agonists, represent one of the most revolutionary advancements in the global pharmaceuticals industry. The Roundhill GLP-1 & Weight Loss ETF (“OZEM”) is the world’s first GLP-1 ETF. OZEM is an actively-managed ETF.
Similar ETFs
The Roundhill Investments - GLP-1 & Weight Loss ETF (OZEM) is an exchange-traded fund issued by Roundhill Investments that launched on May 21, 2024. It currently manages $57.0M in assets under management. The fund charges an expense ratio of 0.59%. The fund holds 29 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 66.4% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly & Co | 16.58% | 9,543 | $9.3M |
| 2 | NVO | Novo Nordisk A/S | 13.17% | 194,904 | $7.4M |
| 3 | PFE | Pfizer Inc | 7.01% | 146,749 | $3.9M |
| 4 | VKTX | Viking Therapeutics Inc | 5.59% | 88,599 | $3.1M |
| 5 | 1801.HK | Innovent Biologics Inc | 4.77% | 257,000 | $2.7M |
| 6 | 1672.HK | Ascletis Pharma Inc | 4.18% | 1,201,000 | $2.4M |
| 7 | AMGN | Amgen Inc | 3.99% | 6,102 | $2.2M |
| 8 | ROG.SW | Roche Holding AG | 3.93% | 5,456 | $2.2M |
| 9 | 4519.T | Chugai Pharmaceutical Co Ltd | 3.65% | 34,700 | $2.1M |
| 10 | AZN | AstraZeneca PLC | 3.56% | 10,409 | $2.0M |
| 11 | 128940.KS | Hanmi Pharm Co Ltd | 3.47% | 5,923 | $2.0M |
| 12 | REGN | Regeneron Pharmaceuticals Inc | 3.12% | 2,348 | $1.8M |
| 13 | ZEAL.CO | Zealand Pharma A/S | 3.11% | 43,135 | $1.7M |
| 14 | 2196.HK | Shanghai Fosun Pharmaceutical Group Co Ltd | 3.09% | 702,000 | $1.7M |
| 15 | 3933.HK | United Laboratories International Holdings Ltd/The | 2.95% | 1,010,000 | $1.7M |
Detailed Returns
| Period | Return | ETF | Cat. Avg | vs Avg |
|---|---|---|---|---|
| 1D | -0.59% | — | ||
| 1W | -1.07% | — | ||
| 1M | -11.03% | — | ||
| 3M | -8.98% | — | ||
| 6M | +22.42% | — | ||
| YTD | -8.02% | — | ||
| 1Y | +29.45% | — | ||
| 3Y | +24.50% | — | ||
| 5Y | +24.50% | — |
Moving Averages
20-Day MA
$33.97
Below 20-Day MA50-Day MA
$34.85
Below 50-Day MA200-Day MA
$29.26
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$37.01
Current Price
$31.40
52-Week Low
$20.67
$20.67$37.01
Current Yield
1.27%
Annual Dividend
$0.4630
Frequency
1x/year
Last Ex-Date
Dec 30, 2025
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Dec 30, 2025 | $0.4099 | Dec 31, 2025 |
| Dec 30, 2024 | $0.0531 | Dec 31, 2024 |
Dividend Payments Over Time
Category Comparison
| Metric | OZEM | Healthcare(223 ETFs) | Pharma(29 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.59% | 0.60% | 0.66% |
| AUM | $57.0M | $1.24B | $1.49B |
| Dividend Yield | 1.27% | 2.75% | 1.85% |
| Avg Volume | 27.6K | 800.9K | 973.9K |
| Holdings | 29 | 171 | 43 |
| Performance | |||
| 1-Month Return | -11.29% | -4.57% | -3.99% |
| 6-Month Return | +22.02% | +4.90% | +13.94% |
| YTD Return | -7.53% | -1.70% | -0.82% |
| 1-Year Return | +31.71% | +15.18% | +17.98% |
Compare with Another ETF
Search for an ETF to compare with OZEM: